Status:
COMPLETED
Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Eye Diseases
Eligibility:
All Genders
6+ years
Brief Summary
This study will collect blood samples from patients with non-infectious eye inflammatory diseases a spectrum of eye disorders that can produce sight-threatening vision loss. The blood will be analyzed...
Detailed Description
Ocular inflammatory diseases can lead to visual loss in adults as well as in children. These conditions are usually characterized by repeated exacerbations and remissions. The underlying cause of majo...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Participant is 6 years or older.
- Adult participant is able to understand and sign the informed consent. If the participant is younger than 18 years of age at enrollment, has a parent or legal guardian who is able to understand and sign the consent on their behalf. Children must provide assent.
- Patients must have a diagnosis of an ocular inflammatory disease, AMD or diabetic retinopathy.
- EXCLUSION CRITERIA:
- The presence of non-ocular inflammatory disease.
- Unwilling or unable to provide a blood sample.
Exclusion
Key Trial Info
Start Date :
April 7 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 24 2018
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT00357071
Start Date
April 7 2003
End Date
July 24 2018
Last Update
July 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892